These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 24006485

  • 1. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β.
    Parvani JG, Galliher-Beckley AJ, Schiemann BJ, Schiemann WP.
    Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.
    Wendt MK, Schiemann WP.
    Breast Cancer Res; 2009 Nov; 11(5):R68. PubMed ID: 19740433
    [Abstract] [Full Text] [Related]

  • 3. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
    Galliher AJ, Schiemann WP.
    Breast Cancer Res; 2006 Nov; 8(4):R42. PubMed ID: 16859511
    [Abstract] [Full Text] [Related]

  • 4. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells.
    Taylor MA, Davuluri G, Parvani JG, Schiemann BJ, Wendt MK, Plow EF, Schiemann WP, Sossey-Alaoui K.
    Breast Cancer Res Treat; 2013 Nov; 142(2):341-53. PubMed ID: 24197660
    [Abstract] [Full Text] [Related]

  • 5. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
    Carter RZ, Micocci KC, Natoli A, Redvers RP, Paquet-Fifield S, Martin AC, Denoyer D, Ling X, Kim SH, Tomasin R, Selistre-de-Araújo H, Anderson RL, Pouliot N.
    J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
    [Abstract] [Full Text] [Related]

  • 6. TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer.
    Wendt MK, Schiemann BJ, Parvani JG, Lee YH, Kang Y, Schiemann WP.
    Oncogene; 2013 Apr 18; 32(16):2005-15. PubMed ID: 22710711
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
    Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP.
    Breast Cancer Res; 2014 Mar 11; 16(2):R24. PubMed ID: 24618085
    [Abstract] [Full Text] [Related]

  • 8. Enhanced Expression of Integrin αvβ3 Induced by TGF-β Is Required for the Enhancing Effect of Fibroblast Growth Factor 1 (FGF1) in TGF-β-Induced Epithelial-Mesenchymal Transition (EMT) in Mammary Epithelial Cells.
    Mori S, Kodaira M, Ito A, Okazaki M, Kawaguchi N, Hamada Y, Takada Y, Matsuura N.
    PLoS One; 2015 Mar 11; 10(9):e0137486. PubMed ID: 26334633
    [Abstract] [Full Text] [Related]

  • 9. Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer.
    Salvo E, Garasa S, Dotor J, Morales X, Peláez R, Altevogt P, Rouzaut A.
    Mol Cancer; 2014 May 19; 13():112. PubMed ID: 24884715
    [Abstract] [Full Text] [Related]

  • 10. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
    Park CY, Min KN, Son JY, Park SY, Nam JS, Kim DK, Sheen YY.
    Cancer Lett; 2014 Aug 28; 351(1):72-80. PubMed ID: 24887560
    [Abstract] [Full Text] [Related]

  • 11. Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells.
    Taylor MA, Amin JD, Kirschmann DA, Schiemann WP.
    Neoplasia; 2011 May 28; 13(5):406-18. PubMed ID: 21532881
    [Abstract] [Full Text] [Related]

  • 12. Induction of integrin β3 by sustained ERK activity promotes the invasiveness of TGFβ-induced mesenchymal tumor cells.
    Hong SK, Park JR, Kwon OS, Kim KT, Bae GY, Cha HJ.
    Cancer Lett; 2016 Jul 01; 376(2):339-46. PubMed ID: 27085460
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
    Wendt MK, Smith JA, Schiemann WP.
    Oncogene; 2010 Dec 09; 29(49):6485-98. PubMed ID: 20802523
    [Abstract] [Full Text] [Related]

  • 14. Functional Redundancy between β1 and β3 Integrin in Activating the IR/Akt/mTORC1 Signaling Axis to Promote ErbB2-Driven Breast Cancer.
    Bui T, Rennhack J, Mok S, Ling C, Perez M, Roccamo J, Andrechek ER, Moraes C, Muller WJ.
    Cell Rep; 2019 Oct 15; 29(3):589-602.e6. PubMed ID: 31618629
    [Abstract] [Full Text] [Related]

  • 15. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.
    Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP.
    Mol Biol Cell; 2011 Jul 15; 22(14):2423-35. PubMed ID: 21613543
    [Abstract] [Full Text] [Related]

  • 16. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.
    Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, Miller FR, Wu G.
    Cancer Res; 2011 Jul 15; 71(14):4846-56. PubMed ID: 21750175
    [Abstract] [Full Text] [Related]

  • 17. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.
    Galliher-Beckley AJ, Schiemann WP.
    Carcinogenesis; 2008 Feb 15; 29(2):244-51. PubMed ID: 18174260
    [Abstract] [Full Text] [Related]

  • 18. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
    Hedrick E, Lee SO, Doddapaneni R, Singh M, Safe S.
    Mol Cell Biol; 2016 May 15; 36(9):1383-94. PubMed ID: 26929200
    [Abstract] [Full Text] [Related]

  • 19. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
    Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.
    Oncogene; 2013 Dec 12; 32(50):5614-24. PubMed ID: 23955085
    [Abstract] [Full Text] [Related]

  • 20. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA, Parvani JG, Schiemann WP.
    J Mammary Gland Biol Neoplasia; 2010 Jun 12; 15(2):169-90. PubMed ID: 20467795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.